Sana Biotechnology, Inc.

SANA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$42-$94-$49-$49
Dep. & Amort.$3$3$4$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$7$7$6
Change in WC$1-$5-$11$4
Other Non-Cash$9$56$1-$14
Operating Cash Flow-$29-$33-$49-$47
Investing Activities
PP&E Inv.-$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$50$0-$2-$13
Inv. Sales/Matur.$1$0$18$61
Other Inv. Act.$0$8$0$0
Investing Cash Flow-$48$8$17$47
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$110$0$0-$181
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1$1$182
Financing Cash Flow$110$1$1$1
Forex Effect$0$0$0$0
Net Chg. in Cash$32-$25-$31$1
Supplemental Information
Beg. Cash$75$100$131$131
End Cash$108$75$100$131
Free Cash Flow-$29-$33-$49-$48